| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/03/2002 | EP1219300A1 Allergy vaccines |
| 07/03/2002 | EP1219299A1 Allergy vaccines and their preparation |
| 07/03/2002 | EP1218751A2 Diagnosis of coeliac disease using a gliadin epitope |
| 07/03/2002 | EP1218540A2 Transposon mediated differential hybridisation |
| 07/03/2002 | EP1218538A2 Cancer associated antigens and uses therefor |
| 07/03/2002 | EP1218518A1 Dna polymerase lambda and uses thereof |
| 07/03/2002 | EP1218515A2 Regulation with binding cassette transporter protein abc1 |
| 07/03/2002 | EP1218514A1 Designing immunogens |
| 07/03/2002 | EP1218511A1 Antimicrobial compositions |
| 07/03/2002 | EP1218506A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 07/03/2002 | EP1218504A2 Gl50 molecules and uses therefor |
| 07/03/2002 | EP1218499A2 RESCUE OF MUMPS VIRUS FROM cDNA |
| 07/03/2002 | EP1218493A1 Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof |
| 07/03/2002 | EP1218413A2 Engineering antibodies that bind irreversibly |
| 07/03/2002 | EP1218412A2 Human g-protein coupled receptor |
| 07/03/2002 | EP1218408A1 32 human secreted proteins |
| 07/03/2002 | EP1218406A1 Nucleic acids and secreted polypeptides encoded thereby |
| 07/03/2002 | EP1218405A2 Nucleic acid molecule comprising a nucleic acid sequence coding for a hemocyanin |
| 07/03/2002 | EP1218393A1 Cell targeting compositions and methods of using the same |
| 07/03/2002 | EP1218376A1 Tyrosine kinase inhibitors |
| 07/03/2002 | EP1218064A2 Compositions for treating autoimmune disease containing a compounds which regulates icam-lfa-1 interaction and a compounds which regulates cd40-cd40 ligand interaction |
| 07/03/2002 | EP1218037A2 In vivo assay for testing the phenotypic stability |
| 07/03/2002 | EP1218035A2 Rapid peg-modification of viral vectors |
| 07/03/2002 | EP1218032A1 Treatment of refractory human tumors with epidermal growth factor receptor antagonists |
| 07/03/2002 | EP1218031A2 Pharmaceutical composition comprising an antigen |
| 07/03/2002 | EP1218030A1 Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins |
| 07/03/2002 | EP1218029A1 Use of an outer membrane protein a of an enterobacterium associated with a rsv immunogenic peptide for preparing vaccines for intranasal administration |
| 07/03/2002 | EP1217989A1 Liposome-entrapped dna oral vaccines |
| 07/03/2002 | EP1030690B1 Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype |
| 07/03/2002 | EP0813423B1 Composition to inhibit osteolysis and metastasis |
| 07/03/2002 | CN1357047A Recombinant fusion protein (vaccine) compsn. contg. same and method for prodn. thereof |
| 07/03/2002 | CN1357046A Chitinase chitin-binding fragments |
| 07/03/2002 | CN1357045A Outer surface proteins, their genes, and their use |
| 07/03/2002 | CN1357037A Method for preservation of biological-active material |
| 07/03/2002 | CN1357009A Humanized antibody specific for human 4-1BB and pharmaceutical compsn comprising same |
| 07/03/2002 | CN1356911A Method for treatment of fibrosis using antagonist of integrin alpha-4 subunit |
| 07/03/2002 | CN1356910A Model membrane systems |
| 07/03/2002 | CN1356909A Treatment of hemoatological malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody |
| 07/03/2002 | CN1356391A Polypeptide expresxion box |
| 07/03/2002 | CN1356390A Human leukemia associated reverse transcription virus gene and its application |
| 07/03/2002 | CN1356388A Transgenic saline algae bio-reactor |
| 07/03/2002 | CN1356341A Anti-idiotype microantibody and its preparing process and application |
| 07/03/2002 | CN1356142A Therapeutic vaccine for hepatitis B and its preparing process |
| 07/02/2002 | US6414132 Method of eliminating inhibitory/instability regions of mRNA |
| 07/02/2002 | US6414130 Polypeptides binds to extracellular domain, glycosylated polypeptide or monoclonal antibody; antitumor agents |
| 07/02/2002 | US6414117 Compositions and methods for the treatment and diagnosis of immune disorders |
| 07/02/2002 | US6414115 Parasitic nematode transglutaminase proteins and uses thereof |
| 07/02/2002 | US6413940 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis of DMS |
| 07/02/2002 | US6413935 Oligopeptide |
| 07/02/2002 | US6413932 Tek antagonists comprising soluble tek extracellular binding domain |
| 07/02/2002 | US6413771 Respiratory syncytial virus (rsv) fusion protein; treating or preventing rsv infection, as well as for diagnosis of rsv in analytes |
| 07/02/2002 | US6413770 NL4 tie ligand homologue nucleic acid |
| 07/02/2002 | US6413764 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof |
| 07/02/2002 | US6413762 Viral nucleotide sequences |
| 07/02/2002 | US6413759 Streptokinase mutants |
| 07/02/2002 | US6413756 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/02/2002 | US6413740 Nucleic acid which codes for muscle specific kinase c-terminal fragment of human agrin; diagnosis and treatment of muscle disorders and neuromusclar disorders |
| 07/02/2002 | US6413738 House dust mite allergen, Der f VII, and uses therefor |
| 07/02/2002 | US6413550 Proteinoid carriers and methods for preparation and use thereof |
| 07/02/2002 | US6413545 Administering mixture containing plant extracts; appetite suppressant |
| 07/02/2002 | US6413524 spsA polynucleotides and polypeptides |
| 07/02/2002 | US6413523 Pharmaceutical composition of escherichia coli heat-labile enterotoxin adjuvant and methods of use |
| 07/02/2002 | US6413522 Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them |
| 07/02/2002 | US6413521 Helminth parasite antigen with aminopeptidase-like activity |
| 07/02/2002 | US6413520 Methods of immunizing adults using anti-meningococcal vaccine compositions |
| 07/02/2002 | US6413518 Immunologically significant herpes simplex virus antigens and methods for identifying and using same |
| 07/02/2002 | US6413517 Identification of broadly reactive DR restricted epitopes |
| 07/02/2002 | US6413516 Suppression lymphocytes |
| 07/02/2002 | US6413514 Methods of using antibodies against human CD40 |
| 07/02/2002 | US6412492 Mixed chimerism and tolerance |
| 07/02/2002 | CA2223699C In ovo vaccination against coccidiosis |
| 07/02/2002 | CA2184908C Human osteoclast-derived cathepsin |
| 07/02/2002 | CA2123696C Antitumor vaccines |
| 07/02/2002 | CA2083172C Protein d - an igd-binding protein of haemophilus influenzae |
| 07/02/2002 | CA2073486C Composition for the prevention of lyme disease and use for |
| 07/02/2002 | CA2050749C Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations |
| 07/02/2002 | CA2047792C Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines |
| 07/02/2002 | CA1341373C Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates |
| 06/27/2002 | WO2002050284A2 Oxidoreductases |
| 06/27/2002 | WO2002050279A2 Nucleic acid-associated proteins |
| 06/27/2002 | WO2002050278A2 Novel human secreted proteins and polynucleotides encoding the same |
| 06/27/2002 | WO2002050262A2 Mutant mycobacteria for use in therapy |
| 06/27/2002 | WO2002050122A2 Means for the diagnosis and therapy of ctcl |
| 06/27/2002 | WO2002050120A2 High affinity antibodies |
| 06/27/2002 | WO2002050119A2 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/27/2002 | WO2002050116A2 Adhesion molecule protein |
| 06/27/2002 | WO2002050108A2 Immunogenic glycopeptides, screening, preparation and uses |
| 06/27/2002 | WO2002050107A2 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/27/2002 | WO2002050096A1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 06/27/2002 | WO2002049668A1 Use of compatible solutes as adjuvants for vaccines |
| 06/27/2002 | WO2002049667A2 Vaccine for treating nicotine addiction |
| 06/27/2002 | WO2002049666A2 Mycoplasma hyopneumoniae bacterin vaccine |
| 06/27/2002 | WO2002049658A1 A method to enhance the immune system and used for the prevention and treatment of infectious diseases |
| 06/27/2002 | WO2002024147A3 Avian pneumovirus vaccine |
| 06/27/2002 | WO2002022168A3 Vaccine against streptococcus pneumoniae |
| 06/27/2002 | WO2002022167A3 Vaccine against streptococcus penumoniae |
| 06/27/2002 | WO2002020822A3 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 06/27/2002 | WO2002020721A3 Vectors derived from south african arbovirus no. 86 |
| 06/27/2002 | WO2002016548A3 Novel g protein-coupled receptor |
| 06/27/2002 | WO2002009752A3 Immunological adjuvant compounds |